After the successful acceleration of 17 international projects and awarding of the five finalists last year, Open Accelerator (OA) – acceleration program of Zcube research venture from Zambon Group – is scouting again! This year strategically, however, the focus is on the therapeutic areas of Zambon- Central Nervous System (CNS) and Respiratory, including rare diseases in those areas. OA is scouting for projects and startups until the 10th of June, aiming to identify most innovative technologies in the fields of digital health and wearables, big data, drug delivery systems, biomarkers, diagnostics and medical devices.
As a modern pharma company, Zambon follows its mission to “innovate cure and care to make patients’ lives better”. Going “beyond the pill”, it recognizes the ever-growing importance of innovative technologies and the digitalization of healthcare. Therefore, in order to provide an integrated complete solution for the patients, Zambon complements the therapeutics of Zambon Pharma with innovative medical technologies as well as integrated digital tools for the total disease management.
By participating in the OA program most promising entrepreneurs not only have the access to a wide international network of entrepreneurs, scientists, investors, venture capitalists (VCs), and professionals but most importantly, get the chance to co-develop their technologies in collaboration with Zambon as strategic partner. This is an unprecedented opportunity that opens wide horizons and offers to exceptional startups a real “fast-track” go-to-market path. Additionally, upon completion of the acceleration program, the best projects can receive a milestone-based seed investment up to 100,000 euro per project, business consulting service from Deloitte, legal consultations from Bird& Bird and free office space at the Openzone scientific park.
“The strategic focus on the therapeutic areas of Zambon – affirms Giovanni Rizzo, Head of the Open Accelerator – ensures the quality of the program, not only thanks to the active presence of Zambon’s experts, but also to the contribution of partners, collaborators, national and international mentors from different sectors (venture capital, business angels, universities and enterprises). This allows the creation of a vibrant entrepreneurial community with a multidisciplinary approach, which is essential for the successful development of the projects. Furthermore, the OA acceleration program is very unique since it specifically aims to provide the startups personalized sessions to support their individual needs that vary depending on their maturity, technological focus and other factors”.
OA Call for Projects 2018 is open until the 10th of June. Startups working in the fields of drug delivery systems, medical devices, biomarkers, diagnostics, digital health- and big data solutions for CNS and Respiratory diseases can apply via www.openaccelerator.it.